Literature DB >> 15678303

[Methicillin-resistant Staphylococcus aureus. Types of resistance and clinical consequences].

U Geipel1, M Herrmann.   

Abstract

The problem of methicillin-resistant Staphylococcus aureus (MRSA) is on the rise worldwide. However, significant regional differences exist with respect to incidence, types of prevalent outbreak strains and accompanying resistance patterns as well as local conditions and resources to control epidemics. Intensive care units are regularly epicenters of MRSA epidemics. Accordingly, anaesthesists, intensive care physicians and surgeons need to know the established recommendations and guidelines about early recognition and infection control of MRSA, must be familiar with principles of the antimicrobial MRSA therapy, and should adapt the principles for prevention and therapy of MRSA infections to the needs of the respective institution and situation. The result of this process has to be a rational and efficient approach to this nosocomial pathogen allowing its control under consideration of cost effectiveness.

Entities:  

Mesh:

Year:  2005        PMID: 15678303     DOI: 10.1007/s00101-004-0798-6

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  39 in total

1.  A Dutch approach to methicillin-resistant Staphylococcus aureus.

Authors:  J Verhoef; D Beaujean; H Blok; A Baars; A Meyler; C van der Werken; A Weersink
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-07       Impact factor: 3.267

2.  Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management.

Authors:  Dag Harmsen; Heike Claus; Wolfgang Witte; Jörg Rothgänger; Hermann Claus; Doris Turnwald; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 3.  Epidemiology, control and treatment of methicillin-resistant Staphylococcus aureus.

Authors:  G Peters; K Becker
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Smallpox Vaccine Adverse Events Monitoring and Response System for the first stage of the smallpox vaccination program.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-02-07       Impact factor: 17.586

5.  Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection.

Authors:  John J Engemann; Yehuda Carmeli; Sara E Cosgrove; Vance G Fowler; Melissa Z Bronstein; Sharon L Trivette; Jane P Briggs; Daniel J Sexton; Keith S Kaye
Journal:  Clin Infect Dis       Date:  2003-02-07       Impact factor: 9.079

6.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.

Authors:  D Pittet; D Tarara; R P Wenzel
Journal:  JAMA       Date:  1994-05-25       Impact factor: 56.272

7.  The economic impact of Staphylococcus aureus infection in New York City hospitals.

Authors:  R J Rubin; C A Harrington; A Poon; K Dietrich; J A Greene; A Moiduddin
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

8.  Methicillin-resistant Staphylococcus aureus in Europe.

Authors:  A Voss; D Milatovic; C Wallrauch-Schwarz; V T Rosdahl; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

9.  Routine screening for methicillin-resistant Staphylococcus aureus among patients newly admitted to an acute rehabilitation unit.

Authors:  Farrin A Manian; Diane Senkel; Jeanne Zack; Lynn Meyer
Journal:  Infect Control Hosp Epidemiol       Date:  2002-09       Impact factor: 3.254

10.  Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991.

Authors:  A L Panlilio; D H Culver; R P Gaynes; S Banerjee; T S Henderson; J S Tolson; W J Martone
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

View more
  2 in total

Review 1.  Transmission rates, screening methods and costs of MRSA--a systematic literature review related to the prevalence in Germany.

Authors:  A Tübbicke; C Hübner; A Kramer; N-O Hübner; S Fleßa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-10       Impact factor: 3.267

Review 2.  [Methicillin-resistant Staphylococcus (MRSA, MRSE) in the nose, paranasal sinuses and sputum].

Authors:  P Federspil; P A Federspil; U Geipel
Journal:  HNO       Date:  2009-04       Impact factor: 1.284

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.